Ad-hoc | 20 December 2011 07:13
Fresenius Medical Care AG & Co. KGaA / Key word(s): Miscellaneous
20.12.2011 07:13
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Ad-hoc
Bad Homburg, Germany - Fresenius Medical Care AG & Co. KGaA ('the
Company'), the world's largest provider of dialysis products and services,
today announced revised outlook for revenue to be approximately 1.0% to
2.0% below the US-Dollar 13 billion benchmark. The impact on the revenue is
predominately due to significant weakening of the Euro and other currencies
against the US-Dollar in the fourth quarter of 2011. Nevertheless, the
Company continues to confirm its earnings after tax target in US-Dollar
although expectations are that the net income attributable to the Company
will be at the low end of the target range of US-Dollar 1,070-1,090 m,
principally due to the additional one-time costs incurred in 2011 related
to acquisitions.
20.12.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Phone: +49 (0) 6172- 609 2525
Fax: +49 (0) 6172- 609 2301
E-mail: ir@fmc-ag.com
Internet: www.fmc-ag.de
ISIN: DE0005785802, DE0005785836,
WKN: 578580, 578583
Indices: DAX
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart;
Terminbörse EUREX; NYSE
End of Announcement DGAP News-Service
---------------------------------------------------------------------------